Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Teva Canada (@TevaCanadaLtd) / Twitter
Access and Affordability Support
Sharps Disposal Plan for COPAXONE® (glatiramer acetate injection)
A program supporting CINQAIR® (reslizumab) Injection patients
CINQAIR® (reslizumab) Injection - Savings and Support
Cost support for patients prescribed CINQAIR® (reslizumab) Injection
A Guide to the PRESCRIPTION AND SERVICE REQUEST FORM FOR CINQAIR® (reslizumab) Injection
CINQAIR® (reslizumab) Injection - Savings and Support
Cost support for patients prescribed CINQAIR® (reslizumab) Injection
CINQAIR® (reslizumab) Injection - Savings and Support
Upfront | PharmaVoice
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva's Digihaler® Portfolio | Business Wire
A program supporting CINQAIR® (reslizumab) Injection patients
CINQAIR® (reslizumab) Injection - Savings and Support
Certified Nurse Support & Injection Assistance for Your COPAXONE® Therapy
Teva
Patient Support Program for AUSTEDO® | Teva's Shared Solutions®
Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia and AUSTEDO® (deutetrabenazine) tablets
